Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from Polynovo Limited ( (AU:PNV) ) is now available.
JPMorgan Chase & Co. and its affiliates have reduced their voting power in Polynovo Limited from 9.06% to 7.98%, as detailed in a recent notice of change of interests. This adjustment in voting power may influence the company’s shareholder dynamics and could have implications for its governance and decision-making processes.
More about Polynovo Limited
Polynovo Limited operates in the medical technology industry, focusing on the development and commercialization of innovative medical devices. The company’s primary product is NovoSorb, a biodegradable polymer technology used in various medical applications, including wound care and surgical solutions.
YTD Price Performance: -31.83%
Average Trading Volume: 4,406
Technical Sentiment Signal: Buy
Current Market Cap: $492.1M
See more data about PNV stock on TipRanks’ Stock Analysis page.